Explore the details of the Acuitas Therapeutics, Inc. V. Curevac Se case under case number 3:23-cv-00764 involving a cause of action for Patent Non-Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
3:23-cv-00764
Filing Date
Nov 13, 2023
Cause of Action
Patent Non-Infringement
Status
-
Nature of Suit
Patent

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
CureVac SE -
Ying Tam -
Michael Hope -
Acuitas Therapeutics, Inc. -
Barbara Mui -
Paulo Lin -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Nov 13, 2023Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)PACER Document
Nov 13, 2023Notice of Under Seal Filing LCvR5 (B) by Acuitas Therapeutics, Inc., Paulo Lin, Barbara Mui, Ying Tam (McFarland, Robert) (Entered: 11/13/2023)PACER Document
Nov 13, 2023MOTION to file Under Seal by Acuitas Therapeutics, Inc., Paulo Lin, Barbara Mui, Ying Tam. (McFarland, Robert) (Entered: 11/13/2023)PACER Document
Nov 13, 2023Memorandum in Support re 3 MOTION to file Under Seal Inventorship Complaint filed by Acuitas Therapeutics, Inc., Paulo Lin, Barbara Mui, Ying Tam. (Attachments: # 1 Proposed Order)(McFarland, Robert) (Entered: 11/13/2023)PACER Document
Nov 13, 2023Unredacted Document by Acuitas Therapeutics, Inc., Paulo Lin, Barbara Mui, Ying Tam. (Attachments: # 1 Exhibit Ex. A - US11241493, # 2 Exhibit Ex. B - US11471525, # 3 Exhibit Ex. C - US11576966, # 4 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)PACER Document
Nov 13, 2023Financial Interest Disclosure Statement (Local Rule 7.1) by Acuitas Therapeutics, Inc., Paulo Lin, Barbara Mui, Ying Tam. (McFarland, Robert) (Entered: 11/13/2023)PACER Document
Nov 14, 2023Case transferred in from Norfolk Division, Case Number 2:23cv567. (jsmi, )PACER Document
Nov 13, 2023Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)Attachment
Nov 13, 2023Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)Attachment
Nov 13, 2023Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)Attachment
Nov 13, 2023Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)Attachment
Nov 13, 2023Complaint Public Version ( Filing fee $ 402, receipt number AVAEDC-9216699.), filed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Barbara Mui. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit Ex. A- US11241493, # 3 Exhibit Ex. B- US11471525, # 4 Exhibit Ex. C - US11576966, # 5 Exhibit Ex. D - US11596686)(McFarland, Robert) (Entered: 11/13/2023)Attachment
Nov 14, 2023Report on the filing or determination of an action. (adun, ) (Entered: 11/14/2023)PACER Document
Nov 14, 2023ORDER that the undersigned hereby RECUSES himself from all further proceedings in this case in accordance with 28 U.S.C. § 455(a). The Clerk is DIRECTED to randomly reassign this case to another United States District Judge. Signed by District Judge Roderick C. Young on 11/14/2023. (jsmi, ) (Entered: 11/14/2023)PACER Document
Nov 14, 2023Case reassigned to District Judge M. Hannah Lauck. District Judge Roderick C. Young no longer assigned to the case. (jsmi, )PACER Document
Nov 28, 2023WAIVER OF SERVICE Returned Executed by Paulo Lin, Acuitas Therapeutics, Inc., Ying Tam, Michael Hope, Barbara Mui. CureVac SE waiver sent on 11/28/2023, answer due 2/26/2024. (McFarland, Robert) (Entered: 11/28/2023)PACER Document
Nov 28, 2023MOTION to Transfer Case and Unapposed Memo in Support by Acuitas Therapeutics, Inc., Michael Hope, Paulo Lin, Barbara Mui, Ying Tam. (McFarland, Robert) (Entered: 11/28/2023)PACER Document
Nov 28, 2023ORDER- This matter comes before the Court sua sponte. Upon due consideration, the Court finds it in the interest of judicial efficiency to reassign this case. The Clerk is DIRECTED to transfer this case to the Norfolk Division. Judge Jamar K. Walker is currently assigned a related case, BioNTech SE v. Cure Vac SE, 2:23cv222. Accordingly, the Clerk is DIRECTED to directly assign this matter to Judge Walker. Signed by District Judge M. Hannah Lauck on 11/28/2023. (adun, ) (Entered: 11/28/2023)PACER Document
Nov 28, 2023Intradistrict Transfer to Norfolk, 2:23cv610 (afar)PACER Document